Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

AIMS: The efficacy and safety of insulin degludec (degludec), a new-generation ultra-long-acting basal insulin, was compared with insulin glargine (glargine) in people with Type 1 diabetes mellitus in a 16-week, open-label, randomized trial. Health status, an important aspect of effective diabetes m...

Descripción completa

Detalles Bibliográficos
Autores principales: Home, P D, Meneghini, L, Wendisch, U, Ratner, R E, Johansen, T, Christensen, T E, Jendle, J, Roberts, A P, Birkeland, K I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397676/
https://www.ncbi.nlm.nih.gov/pubmed/22150786
http://dx.doi.org/10.1111/j.1464-5491.2011.03547.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397676/
https://www.ncbi.nlm.nih.gov/pubmed/22150786
http://dx.doi.org/10.1111/j.1464-5491.2011.03547.x

Ejemplares similares